KEYWORDS
Access, Representation, Population Health, Treatment Considerations, Biological Therapies, Immunotherapy, Adverse Events, Biological Processes, Immune Mechanism, Multi-Systemic Interactions, Clinical Practice (Health Services and Quality), Patient Safety, Diseases, Bleeding and Clotting, Thromboembolism, Hemoglobinopathies, Sickle Cell Disease, Thalassemia, Research, Clinical Research, Real-World Evidence, Study Population, Human, Adult